NASDAQ
4.51USD
-0.24 (-5.05%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
6.4M
P/E
—
EPS
—
Beta
-2.74
52W range
3.58-183.6
Day range
4.38–4.71
Open
4.71
Prev close
4.75
Volume
965
Avg volume
8.3K
Dividend
0.00
IPO
2025-08-26
https://www.prnewswire.com/news-releases/wolf-haldenstein-adler-freeman--herz-llp-is-investigating-potential-securities-fraud-claims-on-behalf-of-the-shareholders-of-curanex-pharmaceuticals-inc-nasdaq-curx-302770664.html · 5/18/2026-1.00
https://www.globenewswire.com/news-release/2026/05/14/3294973/0/en/Curanex-Reports-First-Quarter-2026-Business-Progress-as-Phyto-N-Advances-Toward-Planned-FDA-Submission.html · 5/14/2026+0.80
https://www.prnewswire.com/news-releases/wolf-haldenstein-adler-freeman--herz-llp-is-investigating-potential-securities-fraud-claims-on-behalf-of-the-shareholders-of-curanex-pharmaceuticals-inc-nasdaq-curx-302770085.html · 5/12/2026-1.00
https://www.globenewswire.com/news-release/2026/05/01/3285641/0/en/DGNX-Investors-Have-Opportunity-to-Join-Diginex-Limited-Fraud-Investigation-with-the-Schall-Law-Firm.html · 5/1/2026
https://www.globenewswire.com/news-release/2026/04/08/3270018/0/en/Curanex-Highlights-Five-Additional-Patient-Cases-Further-Supporting-the-Potential-of-Its-Lead-Candidate-in-Cancer-Cachexia-Advanced-Cancer-Supportive-Care-and-Severe-Systemic-Decli.html · 4/8/2026+1.00
https://www.globenewswire.com/news-release/2025/09/12/3149402/0/en/Curanex-Pharmaceuticals-Inc-Announces-Exercise-of-the-Over-Allotment-Option-by-Underwriters.html · 9/12/2025+0.40
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
